TNFRSF8 and mature T-cell and NK-cell non-Hodgkin lymphoma: To test whether 9C11-2 CAR T cells exhibit antitumor efficacy toward CD30-positive human PTCL tumors in vivo, we established a Karpas 299 xenograft NCG mouse model.